REGENXBIO Inc v. Sarepta Therapeutics, Inc.

 
APPEAL NO.
24-1408
OP. BELOW
DCT
SUBJECT
Patent
AUTHOR
Stoll

Question(s) Presented

“Whether routine manipulation of a naturally occurring DNA sequence, without more, is sufficient to confer patent eligibility under 35 U.S.C. §101.”

Date
Selected Proceedings and Orders